Eularis Newsroom - Profile and News Archive

NEW YORK, N.Y., Aug. 2, 2016 (SEND2PRESS NEWSWIRE) — Eularis announces the release of their one-day Masterclass “Using Artificial Intelligence to Transform Sales and Revenue: What Pharma Need to Know.” Many Pharma sales and marketing teams do not understand the relevance, nor the critical importance, of AI to achieve stronger results in their roles, and believe it is not relevant to them or their job. This is an incorrect assumption.

NEW YORK, N.Y. and Tokyo, Sept. 15, 2015 (SEND2PRESS NEWSWIRE) — Eularis announces today the release of E-VAI, the latest development in sophisticated artificial intelligence technology delivering next generation analytics and decision making to Pharma marketers globally. E-VAI changes the game for marketers struggling to understand and get value from their marketing.

LONDON, U.K. (SEND2PRESS NEWSWIRE) — The pharmaceutical industry is facing unprecedented challenges on many fronts – a slew of patient expiries, a lack of blockbusters in the pipeline to replace the patent expiries, decreasing growth in many major markets, generic competition, constantly changing regulatory and competitive environment rendering old tools for analysis obsolete, increased pressure on CEOs to deliver shareholder growth resulting in budget cuts, downsizing, and less than optimal results.

NEW YORK, N.Y. and LONDON, U.K. (SEND2PRESS NEWSWIRE) — Eularis is announcing the release of its report ‘How To Harness The Power Of Social Media In Pharmaceutical eMarketing.’ This report puts to rest the issues around ‘can’t,’ and shows Pharmaceutical marketers how they can utilize social media networks effectively to meet their marketing objectives.

NEW YORK, N.Y., and LONDON, U.K., May 18 (SEND2PRESS NEWSWIRE) — Eularis is announcing the release of an update to its report ‘Pharmaceutical eMarketing: Building Brands, Relationships & Business Through Web 2.0 and Beyond.’ The comprehensive report has been created to demystify the world of eMarketing and Social Media to provide Pharmaceutical marketers with a competitive edge and the latest information on how to use these emerging tools.

LONDON, U.K., May 18 (SEND2PRESS NEWSWIRE) — Dr. Andree Bates, President of the Pharmaceutical analytics company Eularis, will be delivering a MasterClass on how to tell if you are making the wrong marketing decision. The Pharmaceutical Industry is under significant pressure to consider its costs very carefully. Since marketing budgets often represent a major portion of a company’s cost base, they can easily become the target of budget cuts. The pressure to measure marketing return and effectiveness has never been stronger.

LONDON UK, and TOKYO Japan, July 7 (SEND2PRESS NEWSWIRE) — With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years.

LONDON, UK and TOKYO Japan, June 30 (SEND2PRESS NEWSWIRE) — Eularis is announcing the release of an update to its report, Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line. Originally offered in February 2007, the comprehensive report has been revised to provide pharmaceutical marketers with a competitive edge and the latest research information.

TOKYO and LONDON, U.K., May 12 (SEND2PRESS NEWSWIRE) — Dr. Andree Bates, president of the New York and London-based pharmaceutical analytics company Eularis, will be delivering a presentation on how to tell if you are making the wrong marketing decision. The Pharmaceutical Marketing Excellence conference takes place in Tokyo, Japan.

LONDON, U.K. and NEW YORK, N.Y. – Nov. 20 (SEND2PRESS NEWSWIRE) — With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years.

NEW YORK, N.Y. and LONDON, U.K. – Nov. 20 (SEND2PRESS NEWSWIRE) — Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on marketing return at the Pharmaceutical Marketing Society Half-day Conference: ROI or RIP. At 2:30 p.m. on Monday 26 November 2007, Dr. Bates will deliver a presentation titled, ‘What Can Be Measured?’

NEW YORK, N.Y. and LONDON, U.K. – Sept. 24 (SEND2PRESS NEWSWIRE) — Campbell Belman, an established pharmaceutical analytics company, today introduces its new name: Eularis. This announcement reflects the significant growth the Company has achieved across its full range of pharmaceutical analytics products, which have helped tailor the advertising and marketing programs of its global top-tier clients.